Published in Br J Pharmacol on September 01, 1993
Activation of A2-purinoceptors by adenosine stimulates L-arginine transport (system y+) and nitric oxide synthesis in human fetal endothelial cells. J Physiol (1997) 1.06
Insulin restores gestational diabetes mellitus-reduced adenosine transport involving differential expression of insulin receptor isoforms in human umbilical vein endothelium. Diabetes (2011) 0.99
Insulin-increased L-arginine transport requires A(2A) adenosine receptors activation in human umbilical vein endothelium. PLoS One (2012) 0.91
Enhanced nitric oxide activity offsets peripheral vasoconstriction during acute hypoxaemia via chemoreflex and adrenomedullary actions in the sheep fetus. J Physiol (2003) 0.86
Role of nitric oxide in placental vascular development and function. Placenta (2011) 0.86
Adenosine mediates metabolic and cardiovascular responses to hypoxia in fetal sheep. J Physiol (1995) 0.85
Adenosine A₂a receptors and O₂ sensing in development. Am J Physiol Regul Integr Comp Physiol (2011) 0.81
Purinergic signalling in the reproductive system in health and disease. Purinergic Signal (2013) 0.78
Maternal hypoxia and caffeine exposure depress fetal cardiovascular function during primary organogenesis. J Obstet Gynaecol Res (2012) 0.76
Insulin requires A1 adenosine receptors expression to reverse gestational diabetes-increased L-arginine transport in human umbilical vein endothelium. Purinergic Signal (2015) 0.76
Calcitonin gene-related peptide contributes to the umbilical haemodynamic defence response to acute hypoxaemia. J Physiol (2004) 0.75
The physiological activity of adenine compounds with especial reference to their action upon the mammalian heart. J Physiol (1929) 23.79
Is there a basis for distinguishing two types of P2-purinoceptor? Gen Pharmacol (1985) 9.20
L-arginine is the physiological precursor for the formation of nitric oxide in endothelium-dependent relaxation. Biochem Biophys Res Commun (1988) 7.77
A novel receptor-operated Ca2+-permeable channel activated by ATP in smooth muscle. Nature (1987) 5.94
[3H]CGS 21680, a selective A2 adenosine receptor agonist directly labels A2 receptors in rat brain. J Pharmacol Exp Ther (1989) 4.18
Cardiovascular purinoceptors. Physiol Rev (1990) 3.70
Adenosine receptors: targets for future drugs. J Med Chem (1982) 3.44
NG-nitro-L-arginine (N5-[imino(nitroamino)methyl]-L-ornithine) impairs endothelium-dependent dilations by inhibiting cytosolic nitric oxide synthesis from L-arginine. Naunyn Schmiedebergs Arch Pharmacol (1990) 2.55
CGS 21680C, an A2 selective adenosine receptor agonist with preferential hypotensive activity. J Pharmacol Exp Ther (1989) 1.99
P2-purinoceptors mediate both vasodilation (via the endothelium) and vasoconstriction of the isolated rat femoral artery. Eur J Pharmacol (1985) 1.71
Different P2-purinergic receptor subtypes of endothelium and smooth muscle in canine blood vessels. J Pharmacol Exp Ther (1987) 1.63
Regulation of P2y-purinoceptor-mediated prostacyclin release from human endothelial cells by cytoplasmic calcium concentration. Br J Pharmacol (1988) 1.48
Characteristics of the P2 purinoceptor that mediates prostacyclin production by pig aortic endothelial cells. Eur J Pharmacol (1987) 1.48
2-Chloro-N6-cyclopentyladenosine: a highly selective agonist at A1 adenosine receptors. Naunyn Schmiedebergs Arch Pharmacol (1988) 1.47
Evidence for two types of P2-purinoceptor in longitudinal muscle of the rabbit portal vein. Eur J Pharmacol (1985) 1.43
Ligand selectivity of dog coronary adenosine receptor resembles that of adenylate cyclase stimulatory (Ra) receptors. J Pharmacol Exp Ther (1983) 1.31
Purine-mediated relaxation and constriction of isolated rabbit mesenteric artery are not endothelium-dependent. Eur J Pharmacol (1985) 1.29
3,7-Dimethyl-1-propargylxanthine: a potent and selective in vivo antagonist of adenosine analogs. Life Sci (1988) 1.26
Adenosine concentration in umbilical cord blood of newborn infants after vaginal delivery and cesarean section. Pediatr Res (1989) 1.17
Nitric oxide is the mediator of ATP-induced dilatation of the rabbit hepatic arterial vascular bed. Br J Pharmacol (1991) 1.12
Evidence suggesting an Ra-type adenosine receptor in bovine coronary arteries. J Pharmacol Exp Ther (1985) 1.10
The measurement of hypoxanthine, xanthine, inosine and uridine in umbilical cord blood and fetal scalp blood samples as a measure of fetal hypoxia. Br J Obstet Gynaecol (1981) 1.06
Characterization of adenosine receptors in isolated cerebral arteries of cat. Br J Pharmacol (1983) 1.02
Characterization of P2X- and P2Y-purinoceptors in the rabbit hepatic arterial vasculature. Br J Pharmacol (1991) 1.00
Effects of vasoactive autacoids on the human umbilical-fetal placental vasculature. Br J Obstet Gynaecol (1984) 0.98
An in vitro analysis of purine-mediated renal vasoconstriction in rat isolated kidney. Br J Pharmacol (1987) 0.93
Further characterization of the renovascular effects of N6-cyclohexyladenosine in the isolated perfused rat kidney. J Pharmacol Exp Ther (1987) 0.92
Hypoxia-induced fetoplacental vasoconstriction in perfused human placental cotyledons. Am J Obstet Gynecol (1987) 0.89
Role of endothelium-derived nitric oxide in maintenance of low fetal vascular resistance in placenta. Lancet (1991) 0.87
Studies of a single placental cotyledon in vitro: I. The preparation and its viability. Placenta (1981) 0.87
The effects of adenosine triphosphate (ATP) and related purines on human isolated subcutaneous and omental resistance arteries. Br J Pharmacol (1991) 0.84
Binding characteristics of an adenosine receptor in human placenta. J Biol Chem (1983) 0.84
Vasodilatory effects of adenosine A2 receptor agonists CGS 21680 and CGS 22492 in human vasculature. Eur J Pharmacol (1992) 0.83
An investigation of the receptors involved in the coronary vasodilatory effect of adenosine analogues. Clin Exp Pharmacol Physiol (1986) 0.82
Evidence for inhibition by endothelium-derived relaxing factor of thromboxane A2 receptor-mediated vasoconstriction in the fetal vessels of the human perfused placenta. Placenta (1993) 0.81
Autacoids and the control of vascular tone in the human umbilical-placental circulation. Placenta (1992) 0.81
Determination of adenosine in fetal perfusates of human placental cotyledons using fluorescence derivatization and reversed-phase high-performance liquid chromatography. Anal Biochem (1988) 0.79
Presence of adenosine in the human term placenta. Determination of adenosine content and pathways of adenosine metabolism. Circ Res (1972) 0.79
Effects of clonidine and guanethidine on peripheral sympathetic nerve function in the pithed rat. Br J Pharmacol (1973) 2.50
Actions of etorphine hydrochloride, (M99): a potent morphine-like agent. Br J Pharmacol Chemother (1967) 2.03
Topical guanethidine relieves dentinal hypersensitivity and pain. J R Soc Med (1994) 1.39
Observations on the pharmacological properties of inflammatory exudate. Eur J Pharmacol (1969) 1.29
The effect of adrenergic neurone blockade on responses of the cat heart to sympathetic nerve stimulation. Br J Pharmacol (1970) 1.24
The pharmacology of N-(cyclopropylmethyl)-19-isopentylnororvinol hydrochloride. A potent and long lasting central depressant. Br J Pharmacol Chemother (1966) 1.20
Prediction and early diagnosis of preterm labor: a critical review. Obstet Gynecol Surv (1993) 1.19
Noradrenergic neurone blocking agents. J Auton Pharmacol (1981) 1.18
Relative susceptibility of peripheral sympathetic nerves to adrenergic neurone blockade by bethanidine. Br J Pharmacol (1970) 1.14
Angiotensins I and II, active and inactive renin, renin substrate, renin activity, and angiotensinase in human liquor amnii and plasma. Am J Obstet Gynecol (1975) 1.12
Arterial reactivity is enhanced in genetic males taking high dose estrogens. J Am Coll Cardiol (1997) 1.12
Methods of recording fetal movement. Br J Obstet Gynaecol (1977) 1.10
Cigarette smoke inhalation specifically inhibits depressor responses to prostacyclin in the rat. Br J Pharmacol (1981) 1.09
Cardiac output at rest during pregnancy and the puerperium. Clin Sci (1966) 1.06
Postural influence on maternal capillary oxygen and carbon dioxide tension. Br Med J (1969) 1.05
Clinical features of eight pregnancies resulting from in vitro fertilization and embryo transfer. Fertil Steril (1982) 1.04
A comparison of the vasodepressor effects of the cyclic effects of the cyclic endoperoxides PGG, and PGH2 with those of PGD2 and PGE2 in hypertensive and normotensive rats. Eur J Pharmacol (1976) 1.00
Uptake of etorphine and dihydromorphine after sublingual and intramuscular administration. Eur J Pharmacol (1969) 0.98
Effects of oestrogens on the human circulation. J Obstet Gynaecol Br Commonw (1970) 0.98
Haemodynamic changes in women taking oral contraceptives. J Obstet Gynaecol Br Commonw (1970) 0.98
Effects of vasoactive autacoids on the human umbilical-fetal placental vasculature. Br J Obstet Gynaecol (1984) 0.98
A trial of oral ritodrine for the prevention of premature labour. Br J Obstet Gynaecol (1977) 0.96
Cardiovascular dynamics in women receiving oral contraceptive therapy. Lancet (1969) 0.95
Corticotropin-releasing hormone-induced vasodilatation in the human fetal-placental circulation: involvement of the nitric oxide-cyclic guanosine 3',5'-monophosphate-mediated pathway. J Clin Endocrinol Metab (1995) 0.94
Synergistic potentiation by captopril and propranolol of bradykinin-induced bronchoconstriction in the guinea-pig. Clin Exp Pharmacol Physiol (1989) 0.92
Medical audit of hysterectomy in the Hunter Area of New South Wales. Aust Clin Rev (1992) 0.90
Vasodilator actions of urocortin and related peptides in the human perfused placenta in vitro. J Clin Endocrinol Metab (1998) 0.90
Symptoms during normal pregnancy: a prospective controlled study. Aust N Z J Obstet Gynaecol (1999) 0.88
The effects of chronic maternal hypotension during pregnancy. Aust N Z J Obstet Gynaecol (1992) 0.88
Converting enzyme inhibition in the rat by captopril is accompanied by potentiation of carrageenin-induced inflammation. Br J Pharmacol (1984) 0.87
Haemoglobin Bart's hydrops fetalis syndrome in an infant of Greek origin and prenatal diagnosis of alpha-thalassaemia. Med J Aust (1979) 0.86
Release of prostaglandins during contraction of the human umbilical vein on reduction of temperature. Br J Pharmacol (1979) 0.86
The effects of chronic high dose androgen or estrogen treatment on the human prostate [corrected]. J Clin Endocrinol Metab (1996) 0.85
Changes in cardiovascular sensitivity of alloxan-treated diabetic rats to arachidonic acid. Br J Pharmacol (1986) 0.85
The effects of Al3+, Cd2+ and Mn2+ on human erythrocyte choline transport. Biochem Pharmacol (1983) 0.85
An antitussive test using guinea-pigs. Br J Pharmacol (1970) 0.84
Subjective recording of fetal movement. Br J Obstet Gynaecol (1979) 0.83
U46619-mediated vasoconstriction of the fetal placental vasculature in vitro in normal and hypertensive pregnancies. J Hypertens (1999) 0.82
Evidence for peripheral mechanisms mediating the antitussive actions of opioids in the guinea pig. Gen Pharmacol (1991) 0.82
Autacoids and the control of vascular tone in the human umbilical-placental circulation. Placenta (1992) 0.81
Evidence for inhibition by endothelium-derived relaxing factor of thromboxane A2 receptor-mediated vasoconstriction in the fetal vessels of the human perfused placenta. Placenta (1993) 0.81
The effects of N-(cyclopropylmethyl)-19-isopentylnororvinol (M320), a potent agonist at kappa- and mu-opiate receptors, on urine excretion of rats. Br J Pharmacol (1986) 0.81
Hypertensive and normal pregnancy: a longitudinal study of blood pressure, distensibility of dorsal hand veins and the ratio of the stable metabolites of thromboxane A2 and prostacyclin in plasma. Br J Obstet Gynaecol (1995) 0.80
Haemodynamic changes and left ventricular performance during high-dose oestrogen administration to male transsexuals. Br J Obstet Gynaecol (1986) 0.80
Self-reported long-term outcomes of hysterectomy. Br J Obstet Gynaecol (1991) 0.80
Corticotropin-releasing hormone-induced vasodilatation in the human fetal placental circulation. J Clin Endocrinol Metab (1994) 0.80
Characterization of thromboxane A2 receptors in the human fetal placental vessels and umbilical vein. Clin Exp Pharmacol Physiol (1986) 0.80
Effects of endothelial cell removal on alpha-adrenoceptor-mediated responses of aortae of pregnant rats. Clin Exp Pharmacol Physiol (1990) 0.80
Effects of oral contraceptive therapy on the renin-angiotensin system. J Clin Endocrinol Metab (1971) 0.79
Release of a substance from the human placenta having digoxin-like immunoreactivity. Clin Exp Pharmacol Physiol (1993) 0.79
Actions of magnesium, nifedipine and clonidine on the fetal vasculature of the human placenta. Aust N Z J Obstet Gynaecol (1996) 0.79
Analysis of mid-trimester corticotrophin-releasing hormone and alpha-fetoprotein concentrations for predicting pre-eclampsia. Hum Reprod (2000) 0.79
Common medical disorders in pregnancy and their treatment. Drugs (1980) 0.79
Autacoids and control of human placental blood flow. Clin Exp Pharmacol Physiol (1994) 0.79
Effect of inhibition of nitric oxide synthase and guanylate cyclase on hydralazine-induced vasodilatation of the human fetal placental circulation. Clin Exp Pharmacol Physiol (1994) 0.78
Effects of endothelial cell removal on constrictor and dilator responses of aortae of pregnant rats. J Auton Pharmacol (1989) 0.78
Attenuation by captopril of pressor responses to sympathetic stimuli: effects of procedures reducing activity of the renin-angiotensin system. J Auton Pharmacol (1983) 0.77
Thromboxane B2 inhibits prostaglandin E2 inactivation by the rat isolated perfused lung. Clin Exp Pharmacol Physiol (1978) 0.77
Functional lateralization of the chicken forebrain revealed by use of intracranial glutamate. Brain Res (1980) 0.77
Vasoactive effects of 8-epi-prostaglandin F(2alpha)in isolated human placental conduit and resistance blood vessels in vitro. Placenta (2001) 0.77
Human luteal tissue prostaglandins, 17 beta-estradiol, and progesterone in relation to the growth and senescence of the corpus luteum. Fertil Steril (1983) 0.77
Plasma levels of atrial natriuretic peptides during pregnancy and post partum in the rat. J Endocrinol (1989) 0.77
Captopril inhibits pressor responses to peripheral sympathetic nerve activation in cats and rats. Clin Exp Pharmacol Physiol Suppl (1982) 0.77
The actions of bretylium: adrenergic neurone blocking and other effects. 1959. Br J Pharmacol (1997) 0.77
Augmented potentiation of renal vasoconstrictor responses by thromboxane A2 receptor stimulation in the alloxan-diabetic rat. J Pharm Pharmacol (1990) 0.77
Regulation of fetal vascular tone in the human placenta. Reprod Fertil Dev (1991) 0.77
Acetylcholine output and foetal vascular resistance of human perfused placental cotyleda. Br J Pharmacol (1986) 0.77
Presynaptic alpha 2-adrenoreceptors affecting terminal synaptic transmission by the nervi cardiaci accelerantes in the rat. J Auton Pharmacol (1989) 0.77
Effects of morphine, H-Tyr-D-Arg-Phe-Lys-NH2 (DALDA) and B-HT920 on non-cholinergic nerve-mediated bronchoconstriction in pithed guinea-pigs. Br J Pharmacol (1990) 0.77
Large meningioma complicating pregnancy. Aust N Z J Obstet Gynaecol (1997) 0.76
Attenuation by captopril of pressor responses to peripheral sympathetic nerve stimulation in rats is abolished after bilateral nephrectomy and during mineralocorticoid hypertension. Clin Exp Pharmacol Physiol (1983) 0.76
Ovarian stromal and luteal tissue prostaglandins, 17 beta-estradiol, and progesterone in relation to the phases of the menstrual cycle in women. Am J Obstet Gynecol (1987) 0.76
Venous distensibility during the menstrual cycle. Br J Obstet Gynaecol (1977) 0.76
Effects of Bufo marinus skin toxins on human fetal extracorporeal blood vessels. Toxicon (1997) 0.76
Fetal placental vascular responses to corticotropin-releasing hormone in vitro. Effects of variation in oxygen tension. Placenta (2000) 0.76
Amniocentesis in the early second trimester of pregnancy and maternal anxiety. Aust Fam Physician (1979) 0.76
Effects of nitrovasodilators on the human fetal-placental circulation in vitro. Placenta (2001) 0.76
Myometrial prostaglandins during the human menstrual cycle. Am J Obstet Gynecol (1981) 0.75
Some factors affecting inactivation of prostaglandin E2 (PGE2) by the rat isolated perfused lung [proceedings]. Br J Pharmacol (1978) 0.75
Precursors of 5-hydroxytryptamine reduce the pressor response to clonidine in the rat [proceedings]. Br J Pharmacol (1977) 0.75
Aortic intubated hypertensive rats: response to drugs and diurnal variations in arterial blood pressure. Br J Pharmacol (1970) 0.75
Methoxyphenamine inhibits basal and histamine-induced nasal congestion in anaesthetized rats. Br J Pharmacol (1990) 0.75
Effects of variation in oxygen tension on responses of the human fetoplacental vasculature to vasoactive agents in vitro. Placenta (1995) 0.75
Effects of pregnancy on the diameter of the uterine arteries in the rabbit. Obstet Gynecol (1968) 0.75